摘要
胰腺癌由于其低切除率和化学耐药性,目前仍然是一个世界级问题和难以解决的负担。早期的诊断和治疗对克服胰腺癌是非常重要的。因此,急需新的诊断和预后生物标记物。在过去,研究人员主要集中于多种癌症的蛋白编码基因和表观遗传变异的研究,并且认为非编码部分没有用。然而近期,长非编码RNA在癌病变过程中是一个主要的作用物,因为它能调整细胞增殖、迁移、侵袭、转移、化疗抵抗等。在此基础上的机制主要集中在信号、诱导、引导、支架方面,但是特异性调整关系目前还未进行报道。几项研究已经揭示了一些长非编码RNA在胰腺癌细胞中参与生物功能时失调。本文我们将简短地概括下在胰腺癌中的功能性长非编码RNA,解释长非编码RNA可能的机制,进一步探索它们在胰腺癌中的重要性。
关键词: 长非编码RNA;胰腺癌;生物标记物;癌变;治疗;靶向
Current Molecular Medicine
Title:Long Non-Coding RNA: An Emerging Paradigm of Pancreatic Cancer
Volume: 16 Issue: 8
Author(s): T. Han, H. Hu, M. Zhuo, L. Wang, J.-J. Cui, F. Jiao, L.-W. Wang
Affiliation:
关键词: 长非编码RNA;胰腺癌;生物标记物;癌变;治疗;靶向
摘要: Pancreatic cancer remains a worldwide issue and burden that is hard to resolve given its low resection rate and chemo-resistance. Early diagnosis and early treatment are critical for conquering pancreatic cancer. Therefore, new biomarkers for diagnosis and prognosis are urgently needed. Previously, researchers mainly focused on protein-coding genetic and epigenetic changes in many types of cancers, and regarded the noncoding part as waste. Recently, however, long non-coding RNA (lncRNA) has emerged as a major participant in carcinogenesis, as it regulates cell proliferation, migration, invasion, metastasis, chemo-resistance, etc. The underlying mechanisms are summarized as signaling, decoy, guide and scaffold, yet the specific regulation networks remain to be uncovered. Several studies have revealed that some lncRNAs are dysregulated in pancreatic cancer, participating in biological functions. In this review, we will briefly outline the functional lncRNAs in pancreatic cancer, decipher possible mechanisms of lncRNAs, and further explore their significance in pancreatic cancer.
Export Options
About this article
Cite this article as:
T. Han, H. Hu, M. Zhuo, L. Wang, J.-J. Cui, F. Jiao, L.-W. Wang , Long Non-Coding RNA: An Emerging Paradigm of Pancreatic Cancer, Current Molecular Medicine 2016; 16 (8) . https://dx.doi.org/10.2174/1566524016666160927095812
DOI https://dx.doi.org/10.2174/1566524016666160927095812 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Calcium Level Controlling Activities of Novel Derivatives of Amlodipine,Riodipine and Cerebrocrast
Letters in Drug Design & Discovery The NK-1 Receptor: A New Target in Cancer Therapy
Current Drug Targets Histone Modifications, Stem Cells and Prostate Cancer
Current Pharmaceutical Design Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
Current Pharmaceutical Biotechnology Development and Clinical Application of Peptide-Based Radiopharmaceuticals
Current Pharmaceutical Design Thiosemicarbazones as Potent Anticancer Agents and their Modes of Action
Mini-Reviews in Medicinal Chemistry Adhesion Molecules in Lung Cancer: Implications in the Pathogenesis and Management
Current Pharmaceutical Design Editorial (A Significant Step Towards New Altitude)
Current Molecular Medicine The Role of Nitric Oxide Synthase Inhibitors in Schizophrenia
Current Medicinal Chemistry Anticancer Evaluation of 3,4,5,4'-trans-tetramethoxystilbene (DMU-212) and Its Analogs Against an Extensive Panel of Human Tumor Cell Lines
Letters in Drug Design & Discovery Epigenetic Modification in Neuropathic Pain
Current Pharmaceutical Design How is Gene Transfection Able to Improve Current Chemotherapy? The Role of Combined Therapy in Cancer Treatment
Current Medicinal Chemistry Diabetes Mellitus: Channeling Care through Cellular Discovery
Current Neurovascular Research Plausible Improvements for Selective Targeting of Dopamine Receptors in Therapy of Parkinson’s Disease
Mini-Reviews in Medicinal Chemistry TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies
Current Medicinal Chemistry SiO2 NPs: Promising Candidates for Drug and Gene Delivery
Drug Delivery Letters Eph Receptor Tyrosine Kinases in Tumor and Tumor Microenvironment
Current Pharmaceutical Design Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System
Current Pharmaceutical Design Pharmacological Modulation of p53 Function in Cancer Therapy
Current Signal Transduction Therapy ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Current Pharmaceutical Design